Literature DB >> 16835882

Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease.

Sheila A Fisher1, Jochen Hampe, Clive M Onnie, Mark J Daly, Christine Curley, Shaun Purcell, Jeremy Sanderson, John Mansfield, Vito Annese, Alastair Forbes, Cathryn M Lewis, Stefan Schreiber, John D Rioux, Christopher G Mathew.   

Abstract

A common haplotype spanning 250 kb on chromosome 5q31 is strongly associated with Crohn disease (CD). Recently, two functional variants within the SLC22A4 and SLC22A5 genes at this locus (IBD5), L503F (c.1507C > T) and G-207C (c.-207G > C), have been proposed to contribute directly to susceptibility to CD. However, extensive linkage disequilibrium at the IBD5 locus has complicated efforts to distinguish causal variants from association of the general risk haplotype. We genotyped the SLC22A4 and SLC22A5 variants and other polymorphisms across the risk haplotype in four populations of European origin, and applied regression-based haplotype analysis to over 1,200 fully genotyped case-control pairs, modeling case/control status on the presence of one or more SNPs to test for conditional association and to identify risk haplotypes. We found highly significant association of SNPs at the IBD5 locus with Crohn disease in all populations tested. However, the frequencies of L503F and G-207C in individuals who did not carry the general IBD5 risk haplotype were not significantly different in cases and controls, with associated disease odds ratios (ORs) of 0.90 (95% CI, 0.57-1.40) and 0.90 (95% CI, 0.65-1.23), respectively. Haplotype analysis showed that addition of the SLC22A4 and SLC22A5 variants to a null model that included the background risk haplotype did not significantly improve the model fit. In addition to the common risk haplotype, several rare haplotypes had an increased frequency in cases compared to controls. This study suggests that the molecular basis for Crohn disease susceptibility at the IBD5 locus remains to be defined, and highlights the challenge of the identification of causal variants in a complex disease in regions of extensive linkage disequilibrium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835882     DOI: 10.1002/humu.20358

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.

Authors:  Prem S Shekhawat; Sonne R Srinivas; Dietrich Matern; Michael J Bennett; Richard Boriack; Varghese George; Hongyan Xu; Puttur D Prasad; Penny Roon; Vadivel Ganapathy
Journal:  Mol Genet Metab       Date:  2007-09-19       Impact factor: 4.797

3.  IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients.

Authors:  Lilla Lakner; Veronika Csöngei; Patrícia Sarlós; Luca Járomi; Eniko Sáfrány; Márta Varga; Péter Orosz; Lili Magyari; Judit Bene; Pál Miheller; Zsolt Tulassay; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2009-02-13       Impact factor: 2.571

4.  Crohn's disease and genetic hitchhiking at IBD5.

Authors:  Chad D Huff; David J Witherspoon; Yuhua Zhang; Chandler Gatenbee; Lee A Denson; Subra Kugathasan; Hakon Hakonarson; April Whiting; Chadwick T Davis; Wilfred Wu; Jinchuan Xing; W Scott Watkins; Michael J Bamshad; Jonathan P Bradfield; Kazima Bulayeva; Tatum S Simonson; Lynn B Jorde; Stephen L Guthery
Journal:  Mol Biol Evol       Date:  2011-08-04       Impact factor: 16.240

5.  Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health.

Authors:  Prem S Shekhawat; Srinivas Sonne; A Lee Carter; Dietrich Matern; Vadivel Ganapathy
Journal:  J Crohns Colitis       Date:  2012-09-21       Impact factor: 9.071

6.  Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.

Authors:  Yukio Kato; Yoshiyuki Kubo; Daisuke Iwata; Sayaka Kato; Tomohisa Sudo; Tomoko Sugiura; Takashi Kagaya; Tomohiko Wakayama; Akiyoshi Hirayama; Masahiro Sugimoto; Kazushi Sugihara; Shuichi Kaneko; Tomoyoshi Soga; Masahide Asano; Masaru Tomita; Toshiyuki Matsui; Morimasa Wada; Akira Tsuji
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

7.  Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Authors:  Ming-Hsi Wang; Toshihiko Okazaki; Subra Kugathasan; Judy H Cho; Kim L Isaacs; James D Lewis; Duane T Smoot; John F Valentine; Howard A Kader; Jean G Ford; Mary L Harris; Maria Oliva-Hemker; Carmen Cuffari; Michael S Torbenson; Richard H Duerr; Mark S Silverberg; John D Rioux; Kent D Taylor; Geoffrey C Nguyen; Yuqiong Wu; Lisa W Datta; Stanley Hooker; Themistocles Dassopoulos; Rick A Kittles; Linda W H Kao; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2012-03-12       Impact factor: 5.325

Review 8.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).

Authors:  Sonne R Srinivas; Puttur D Prasad; Nagavedi S Umapathy; Vadivel Ganapathy; Prem S Shekhawat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-13       Impact factor: 4.052

10.  Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies.

Authors:  Yoichiro Takata; Hiroshi Inoue; Aya Sato; Kazue Tsugawa; Katsutoshi Miyatake; Daisuke Hamada; Fumio Shinomiya; Shunji Nakano; Natsuo Yasui; Toshihito Tanahashi; Mitsuo Itakura
Journal:  J Hum Genet       Date:  2007-12-18       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.